Literature DB >> 1318395

Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats.

S Dandekar1, A M Beebe, J Barlough, T Phillips, J Elder, M Torten, N Pedersen.   

Abstract

A study was undertaken to determine the rate of viral transmission among naive specific-pathogen-free (SPF) cats living in close contact with feline immunodeficiency virus (FIV)-infected cats. Twenty SPF cats were housed in the same rooms with experimentally FIV-infected seropositive and virus culture-positive cats for 2 to 4 years and were monitored for the presence of FIV nucleic acids and antibodies. Only 1 of the 20 cats became seropositive and virus culture positive and developed signs of disease. Genomic DNA from bone marrow and peripheral blood mononuclear cells (PBMC) of 10 of 19 healthy-appearing seronegative cats became positive for FIV DNA by the polymerase chain reaction. Twenty-eight SPF cats housed as groups in separate quarters and never exposed to FIV-infected cats were uniformly negative for FIV DNA. FIV RNA transcripts were detected in concanavalin A-stimulated PBMC cultures from 4 of 10 FIV DNA-positive, seronegative cats by in situ hybridization. PBMC from three of four naive SPF cats acquired FIV nucleic acids after the cats were transfused with blood and bone marrow from FIV genome-positive, seronegative donors. Three of five FIV-seronegative cats housed for years with naturally FIV-infected cats in a private household were also found to harbor FIV DNA, indicating that the same phenomenon occurred in the field. These findings demonstrate that cats living in close contact with FIV-infected seropositive cats can acquire FIV nucleic acids without developing detectable levels of serum antibodies or disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318395      PMCID: PMC241206     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Transmission of retroviral infection by transfusion of seronegative blood in nonhuman primates.

Authors:  T Jehuda-Cohen; J D Powell; K W Sell; F Villinger; E Lockwood; H M McClure; A Ahmed-Ansari
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

Review 2.  HIV infection in pregnancy: epidemiology and clinical management.

Authors:  M G MacDonald; H M Ginzburg; J C Bolan
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

3.  Identification of a CD4 homologue in the cat.

Authors:  C D Ackley; E A Hoover; M D Cooper
Journal:  Tissue Antigens       Date:  1990-02

4.  A feline thymocyte antigen defined by a monoclonal antibody (FT2) identifies a subpopulation of non-helper cells capable of specific cytotoxicity.

Authors:  F W Klotz; M D Cooper
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

5.  Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency.

Authors:  R J Pomerantz; D Trono; M B Feinberg; D Baltimore
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

6.  Detection of HIV RNA by in situ hybridization in peripheral blood mononuclear cells of seronegative children born to HIV-infected mothers.

Authors:  V Wahn; S Sauer; S Vollbach; A Immelmann; B Neumann; A Scheid
Journal:  Eur J Pediatr       Date:  1990-02       Impact factor: 3.183

7.  Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus.

Authors:  D Brunner; N C Pedersen
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro.

Authors:  M Kannagi; T Masuda; T Hattori; T Kanoh; K Nasu; N Yamamoto; S Harada
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

9.  Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection.

Authors:  N C Pedersen; M Torten; B Rideout; E Sparger; T Tonachini; P A Luciw; C Ackley; N Levy; J Yamamoto
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

10.  Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.

Authors:  J K Yamamoto; E Sparger; E W Ho; P R Andersen; T P O'Connor; C P Mandell; L Lowenstine; R Munn; N C Pedersen
Journal:  Am J Vet Res       Date:  1988-08       Impact factor: 1.156

View more
  18 in total

1.  Detection of feline immunodeficiency provirus by seminested polymerase chain reaction.

Authors:  V Celer; H Kulhánková; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

2.  Immunopathologic changes in the thymus during the acute stage of experimentally induced feline immunodeficiency virus infection in juvenile cats.

Authors:  J C Woo; G A Dean; N C Pedersen; P F Moore
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Frequent transmission of immunodeficiency viruses among bobcats and pumas.

Authors:  S P Franklin; J L Troyer; J A Terwee; L M Lyren; W M Boyce; S P D Riley; M E Roelke; K R Crooks; S Vandewoude
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

Review 4.  Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.

Authors:  Sue VandeWoude; Cristian Apetrei
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

5.  Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node.

Authors:  G A Dean; G H Reubel; P F Moore; N C Pedersen
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 6.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

7.  Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity.

Authors:  Malou C Gemeniano; Earl T Sawai; Christian M Leutenegger; Ellen E Sparger
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Relationship between tumor necrosis factor alpha and feline immunodeficiency virus expressions.

Authors:  L A Kraus; W G Bradley; R W Engelman; K M Brown; R A Good; N K Day
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets.

Authors:  A M Beebe; N Dua; T G Faith; P F Moore; N C Pedersen; S Dandekar
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Acute mucosal pathogenesis of feline immunodeficiency virus is independent of viral dose in vaginally infected cats.

Authors:  Kristina E Howard; Stacie K Reckling; Erin A Egan; Gregg A Dean
Journal:  Retrovirology       Date:  2010-01-19       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.